Launch — Access limited to 250 Members to ensure personalized follow-up quality.
The Paradigm

Healthspan > Lifespan

Modern medicine has successfully extended lifespan, but not always healthspan — the years lived in good health. Too often, we spend our last 15 years in a state of decline.

Optimizing longevity is not just to add years to our life, but also life to our years, by aiming for the 'rectangularization of the curve': maintaining optimal physical and cognitive performance for as long as possible, before a rapid but late decline.

Longevity is not a genetic fate (only 20-25%), it's an epigenetic skill (~75-80%) that can be learned. (lien)

Rectangularization of the longevity curve

AgePhysical and cognitive performance
Classic curveSlow and painful decline
Singular curveHigh and long plateau, rapid decline at the end
~25%
Genetics

Share of longevity determined by your genes

~75%
Epigenetics

Share modifiable by your lifestyle

The twelve hallmarks of aging

The landmark review by López-Otín et al. (2023) groups the biological processes of aging into twelve hallmarks. Three new ones were added in 2023 — disabled macroautophagy, chronic inflammation, and dysbiosis. This list frames the entire space of longevity interventions.

Primary hallmarks (causes of damage)

  • ·Genomic instability
  • ·Telomere attrition
  • ·Epigenetic alterations
  • ·Loss of proteostasis
  • ·Disabled macroautophagy

Antagonistic hallmarks (stress responses)

  • ·Deregulated nutrient sensing
  • ·Mitochondrial dysfunction
  • ·Cellular senescence

Integrative hallmarks (systemic consequences)

  • ·Stem cell exhaustion
  • ·Altered intercellular communication
  • ·Chronic low-grade inflammation
  • ·Dysbiosis

Each pillar of the Handbook acts on one or more of these hallmarks: exercise on mitochondrial function and senescence, nutrition on dysbiosis and nutrient sensing, sleep on intercellular communication and inflammation, and so on.

Medicine 3.0: from cure to anticipation

Modern medicine treats declared disease. Medicine 3.0 — a concept popularized by Peter Attia and rooted in Leroy Hood and Lee Hartwell's P4 medicine — proposes a transition toward a proactive, longitudinal, personalized approach.

Three ages of medicine

  • Medicine 1.0. Empirical, observational. From Galen to the late 19th century. Limited understanding of mechanisms.
  • Medicine 2.0. Reactive, evidence-based. Born with microbiology (Pasteur, Koch). Excels at treating declared disease but reasons in binary thresholds (healthy / sick).
  • Medicine 3.0. Proactive, longitudinal, personalized. Continuous biomarker tracking, intervention on weak signals, optimization before symptoms appear.

The "marginal decade"

Without proactive intervention, the last ten years of life are almost always marked by loss of autonomy, cognition, and muscle mass. The compression of morbidity (Fries, 1980) consists of pushing back this marginal decade by maintaining performance as late as possible.

Read the full analysis : Medicine 3.0: from clinical intervention to proactive optimization

Measure biological age, not just chronological

Chronological age tells you nothing about the actual state of your biology. At 50 chronological years, two people can have a 5 to 10-year gap in biological age. Several approaches now make it possible to objectify this gap.

Five families of tools, complementary

  • Epigenetic clocks (Horvath, GrimAge, DunedinPACE) — DNA methylation at CpG sites, median error 3.6 years for Horvath
  • Composite blood biomarkers (KDM method on 10 markers)
  • Plasma proteomics (Lehallier waves, 2019: signatures at 34, 60, and 78 years)
  • Functional measures (gait speed, grip strength, VO₂ max)
  • Integrated scores combining the approaches above

Modulable within weeks

The Fitzgerald pilot trial (2021) demonstrated an average reduction of 3.23 years of epigenetic age in 8 weeks of integrated protocol (nutrition, sleep, exercise, stress management). Trajectory matters more than any single measurement.

The Singular methodology

Singular applies three transversal methodological principles that drive every decision — from the choice of bioactives to the interpretation of biomarkers.

  • Hormesis and U-curve. For each essential nutrient, the optimal dose is neither zero nor infinity: too little creates deficiency, too much creates toxicity. The therapeutic window must be measured, not guessed.
  • N=1 biology. Zeevi et al. (Cell, 2015) demonstrated that two people eating the same food can have radically different glycemic responses. The statistical "average" is not a patient. Any standardized prescription is by construction suboptimal.
  • The five-biomarker method. 25-OH-D, ferritin, erythrocyte magnesium, vitamin B12, and hs-CRP alone cover about 80% of supplementation decisions. The sequence — measure, interpret, calibrate, retest at 3 to 6 months — matters more than the choice of exotic molecules.

This handbook is provided for informational and educational purposes only. It does not constitute the Singular service and does not represent a medical purpose of our platform. For any health questions, consult a healthcare professional.